Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that female pattern hair loss is linked to psychological distress and is hard to diagnose and treat, with its causes still not fully understood.

Trichoscopy is not specific for diagnosing telogen effluvium and both telogen effluvium and androgenetic alopecia often occur together.

Topical finasteride is as effective and safe as minoxidil for treating female pattern hair loss.

Finasteride 5 mg and topical minoxidil 5% effectively increase hair density in women, with finasteride 5 mg having the highest satisfaction.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Minoxidil works faster, but ketoconazole is a safer alternative for female hair loss.

The nutritional supplement improved hair density and reduced hair loss in women with female pattern hair loss.

A systematic approach is crucial for managing hair loss in women.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Thread monofilament and minoxidil together increase hair growth in female androgenetic alopecia.

Higher substance P levels may cause discomfort in hair loss patients.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

Female pattern hair loss in Western India is common and often linked to metabolic syndrome.

Topical spironolactone works better than topical finasteride for hair loss.

Combining fractional CO2 laser with topical dutasteride is more effective for treating male hair loss than using the laser alone.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Using both platelet-rich plasma and minoxidil together gives the best results for hair growth in male rats with hair loss.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

Minoxidil and finasteride effectively treat hair loss.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.